Nov 14 (Reuters)-
Enbio Holdings, Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2025 Sep 30, 2024 Mar 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 5.68 5.96 11.73
(-4.6 pct) (+8.7 pct) (+9.9 pct)
Operating 656 mln 772 mln 953 mln
(-15.0 pct) (+88.7 pct) (+13.6 pct)
Recurring 598 mln 639 mln 844 mln
(-6.4 pct) (+16.5 pct) (+20.2 pct)
Net 543 mln 415 mln 711 mln
(+30.8 pct) (+29.4 pct) (+57.1 pct)
EPS 67.15 yen 51.24 yen 87.80 yen
Ann Div 9.00 yen 9.00 yen
-Q2 div NIL NIL
-Q4 div 9.00 yen 9.00 yen
NOTE - Enbio Holdings, Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6092.T